Article

AMD not made worse by cataract surgery, according to study

According to new research, cataract surgery does not hasten vision loss in people with age-related macular degeneration (AMD).

Washington, DC-According to new research, cataract surgery does not hasten vision loss in people with age-related macular degeneration (AMD). The conclusion of this study challenges the findings of several large epidemiologic studies that suggested a link between cataract surgery and more rapid AMD progress.

Emily Y. Chew, MD, deputy director, Division of Epidemiology and Clinical Research, National Eye Institute, and colleagues analyzed data from 4,577 participants (8,050 eyes), aged 55 to 81 years, who participated in the Age-Related Eye Disease Study (AREDS). Researchers compared the risk of advanced AMD in people who had cataract surgery with those who did not have the surgery.

Little evidence was found by Dr. Chew and her team that cataract surgery influences AMD progression.

Dr. Chew said the conflicting conclusions of this study and previous population-based research is due to the fact that earlier studies may have had unintended biases or confounding variables. Chew also noted that cataract surgery and lens replacement techniques have advanced, and the AREDS participants’ procedures were performed more recently than people included in earlier studies.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.